Application A1357 - Steviol glycosides (rebaudioside M and rebaudioside D) produced by enzymatic conversion using enzymes produced by Escherichia coli BL21

Overview

FSANZ has assessed an application made by Adorvia Biotechnology Co Ltd to permit steviol glycosides with a high rebaudioside M or rebaudioside D content produced by enzymatic conversion using enzymes derived from genetically modified strains of Escherichia coli BL21. FSANZ has prepared a draft food regulatory measure. 

FSANZ has provided public notification and welcomes your submission to assist with consideration of the application.

Consultation papers

The consultation documents and a copy of the application can be accessed from the A1357 webpage on the FSANZ website. Please read these documents before preparing your submission.

Why your views matter

FSANZ invites and welcomes public and stakeholder input into standard setting processes. Your views will help us ensure food standards continue to protect public health and safety while supporting an effective, transparent and accountable regulatory framework for industry and food authorities.

How to make a submission

The Consultation Hub is FSANZ's platform for public consultation. We have set up an online survey response form to assist you in completing your submission. Please refer to the consultation documents in preparing your submission. Once you begin, you can save your progress and complete your submission before the consultation closes on 23 December 2026 at 11:59pm Australian Eastern Daylight Savings Time (AEDT).